A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of mi...
Enregistré dans:
Auteurs principaux: | Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao, Junping Liu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas’s Experience
par: Giuseppe Mangiameli, et autres
Publié: (2021) -
Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
par: Govind Singh Rajawat, et autres
Publié: (2017) -
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
par: Hiroto Yoneda, et autres
Publié: (2021) -
Diagnostic and Prognostic Utility of the Extracellular Vesicles Subpopulations Present in Pleural Effusion
par: Joman Javadi, et autres
Publié: (2021) -
MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
par: Wang Pei, et autres
Publié: (2021)